Gabriel Etienne (Gabriel Étienne)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Newly Diagnosed

Tyrosine Kinase

Chronic Myeloid Leukemia

Top Venues

British journal of haematology

Cancer medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Francois-Xavier Mahon, Markus Pfirrmann, Stephanie Dulucq, Andreas Hochhaus, Panayiotis Panayiotidis, Antonio Almeida, Jiří Mayer, Henrik Hjorth-Hansen, Jeroen J W M Janssen, Mohamed El Missiry, Joaquin Martinez Lopez, Hanne Vestergaard, Hans Ehrencrona, Katerina Machová Poláková, Ulla Olsson-Strömberg, Gert Ossenkoppele, Marc G Berger, Gabriel Etienne, Jolanta Dengler, Tim Henrik Brümmendorf, Andreas Burchert, Delphine Rea, Philippe Rousselot, Franck E Nicolini, Wolf-Karsten Hofmann, Johan Richter, Susanne Saussele, null null, null null
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (16) (2024)
Vincent Alcazer, Stéphane Morisset, Delphine Rea, Laurence Legros, Stephanie Dulucq, Sandrine Hayette, Jean-Michel Cayuela, Françoise Huguet, François-Xavier Mahon, Gabriel Etienne, Franck Emmanuel Nicolini
Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients. British journal of haematology 204 (4) (2024)
Vincent Alcazer, Stéphane Morisset, Delphine Rea, Laurence Legros, Stephanie Dulucq, Sandrine Hayette, Jean-Michel Cayuela, Françoise Huguet, François-Xavier Mahon, Gabriel Etienne, Franck Emmanuel Nicolini
Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients. British journal of haematology (2024)
Francois-Xavier Mahon, Markus Pfirrmann, Stephanie Dulucq, Andreas Hochhaus, Panayiotis Panayiotidis, Antonio Almeida, Jiří Mayer, Henrik Hjorth-Hansen, Jeroen J W M Janssen, Mohamed El Missiry, Joaquin Martinez Lopez, Hanne Vestergaard, Hans Ehrencrona, Katerina Machová Poláková, Ulla Olsson-Strömberg, Gert Ossenkoppele, Marc G Berger, Gabriel Etienne, Jolanta Dengler, Tim Henrik Brümmendorf, Andreas Burchert, Delphine Rea, Philippe Rousselot, Franck E Nicolini, Wolf-Karsten Hofmann, Johan Richter, Susanne Saussele, null null
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Vincent Alcazer, Stéphane Morisset, Delphine Rea, Laurence Legros, Stephanie Dulucq, Sandrine Hayette, Jean-Michel Cayuela, Françoise Huguet, François-Xavier Mahon, Gabriel Etienne, Franck Emmanuel Nicolini
Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients. British journal of haematology 204 (4) (2024)
Stephanie Dulucq, Françoise Rigal-Huguet, Franck Emmanuel Nicolini, Pascale Cony-Makhoul, Martine Escoffre-Barbe, Martine Gardembas, Laurence Legros, Philippe Rousselot, Jixing Liu, Delphine Rea, Véronique De Mas, Sandrine Hayette, Sophie Raynaud, Caroline Lacoste-Roussillon, Fanny Robbesyn, Emilie Klein, Stéphane Morisset, François-Xavier Mahon, Gabriel Etienne
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study. British journal of haematology (2023)
Lydia Roy, Jean-Claude Chomel, Joëlle Guilhot, Agnès Guerci-Bresler, Martine Escoffre-Barbe, Stéphane Giraudier, Aude Charbonnier, Viviane Dubruille, Françoise Huguet, Hyacinthe Johnson-Ansah, Pascal Lenain, Shanti Ame, Gabriel Etienne, Franck Emmanuel Nicolini, Delphine Rea, Pascale Cony-Makhoul, Stéphane Courby, Jean-Christophe Ianotto, Laurence Legros, Antoine Machet, Valérie Coiteux, Eric Hermet, Emilie Cayssials, Stéphane Bouchet, Francois-Xavier Mahon, Philippe Rousselot, François Guilhot, null null
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study). British journal of haematology (2022)
Vincent Marmouset, Justine Decroocq, Sylvain Garciaz, Gabriel Etienne, Amine Belhabri, Sarah Bertoli, Lauris Gastaud, Célestine Simand, Sylvain P Chantepie, Madalina Uzunov, Alexis Genthon, Celine Berthon, Edmond Chiche, Pierre-Yves Dumas, Jacques Vargaftig, Géraldine Salmeron, Emilie Lemasle, Emmanuelle Tavernier, Jérémy Delage, Marion Loirat, Nadine Morineau, Félix Blanc-Durand, Patricia Pautier, Véronique Vergé, Nathalie Auger, Myrtille Thomas, Laetitia Stefani, Marion Lepelley, Thomas Boyer, Sylvain Thépot, Marie-Pierre Gourin, Pascal Bourquard, Matthieu Duchmann, Pierre-Marie Morice, Mauricette Michallet, Lionel Ades, Pierre Fenaux, Christian Recher, Hervé Dombret, Arnaud Pagès, Christophe Marzac, Alexandra Leary, Jean-Baptiste Micol, null null
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Margaux Sevin, Franck Debeurme, Lucie Laplane, Séverine Badel, Margot Morabito, Hanna L Newman, Miguel Torres-Martin, Qin Yang, Bouchra Badaoui, Orianne Wagner-Ballon, Véronique Saada, Dorothée Selimoglu-Buet, Laurence Kraus-Berthier, Sébastien Banquet, Alix Derreal, Pierre Fenaux, Raphaël A Itzykson, Thorsten Braun, Gabriel Etienne, Celine Berthon, Sylvain Thépot, Oliver Kepp, Guido Kroemer, Eric Padron, Maria E Figueroa, Nathalie M Droin, Eric Solary
Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML. Blood 137 (24) (2021)
Jim Canet, Pascale Cony-Makhoul, Sébastien Orazio, Edouard Cornet, Xavier Troussard, Marc Maynadié, Gabriel Etienne, Alain Monnereau
Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit? Cancer medicine 10 (20) (2021)
Philippe Rousselot, Luigina Mollica, Joëlle Guilhot, Agnès Guerci, Franck E Nicolini, Gabriel Etienne, Laurence Legros, Aude Charbonnier, Valérie Coiteux, Caroline Dartigeas, Martine Escoffre-Barbe, Lydia Roy, Pascale Cony-Makhoul, Viviane Dubruille, Martine Gardembas, Françoise Huguet, Delphine Rea, Emilie Cayssials, François Guilhot, Anne Bergeron, Mathieu Molimard, Francois-Xavier Mahon, Jean-Michel Cayuela, Lambert Busque, Stéphane Bouchet
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients. British journal of haematology 194 (2) (2021)
Gabriel Etienne, Carole Faberes, Fréderic Bauduer, Didier Adiko, François Lifermann, Corinne Dagada, Caroline Lenoir, Anna Schmitt, Emilie Klein, Marie-Pierre Fort, Fontanet Bijou, Beatrice Turcq, Fanny Robbesyn, Françoise Durrieu, Laura Versmée, Samia Madene, Marius Moldovan, Sandrine Katsahian, Anais Charles-Nelson, Axelle Lascaux, François-Xavier Mahon, Stéphanie Dulucq
Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors. Cancer medicine 10 (11) (2021)
Stephanie Dulucq, Cyril Astrugue, Gabriel Etienne, François-Xavier Mahon, Antoine Benard
Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta-analysis of studies over the last ten years. British journal of haematology 189 (3) (2020)
Gabriel Etienne, Stephanie Dulucq, Carole Faberes, Fontanet Bijou, Anna Schmitt, Emilie Klein, Marie-Pierre Fort, Françoise Durrieu, Emilie Toulza, François-Xavier Mahon
A single center evaluation of cost savings related to treatment-free remission in chronic myeloid leukemia patients: the prerequisites of a pharmaco-economy larger study. British journal of haematology 189 (3) (2020)
Gabriel Etienne, Stéphanie Dulucq, Françoise Huguet, Anna Schmitt, Axelle Lascaux, Sandrine Hayette, Marie-Pierre Fort, Pierre Sujobert, Fontanet Bijou, Stéphane Morisset, Suzanne Tavitian, Audrey Bidet, Beatrice Turcq, Fanny Robbesyn, Claudine Chollet, Francis Belloc, Françoise Durrieu, François-Xavier Mahon, Franck E Nicolini
Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors. Cancer medicine 8 (11) (2019)
Françoise Huguet, Jean-Michel Cayuela, Nathalie Cambier, Nathalie Carpentier, Malka Tindel, Isabelle Violet, Patricia Zunic, Axelle Lascaux, Gabriel Etienne, null null
Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice. British journal of haematology 187 (5) (2019)